Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
KLA578-1 in Healthy Volunteers
NCT07143318Phase 1Recruiting
- Sponsor
- Hunan Kelun Pharmaceutical
- Start
- Jun 2025
- Primary completion
- May 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of etopcoxib (4 arms), sponsored by Hunan Kelun Pharmaceutical. Primary endpoint: Incidence and severity of adverse events. Started Jun 2025; status: recruiting.
02
Drugs
etopcoxib
Beyond the preview
Go deeper on NCT07143318.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07143318.